The -491 TT apolipoprotein E promoter polymorphism is associated with reduced risk for sporadic Alzheimer's disease

Neuroscience Letters

Volumn 304, Issue 3, 2001, Pages 204-208

  Alvarez Arcaya, Amaya ^a   Combarros, Onofre ^a   Llorca, Javier ^b   Sánchez Guerra, Marisa ^a   Berciano, José ^a   Fernández Luna, José Luis ^a  

^a HOSPITAL UNIVERSITARIO MARQUÉS DE VALDECILLA   (Spain)

^b UNIVERSITY OF CANTABRIA   (Spain)

Author keywords

491 A T polymorphism; Alzheimer's disease; Apolipoprotein E; Polymorphisms

Indexed keywords

APOLIPOPROTEIN E;

ADULT; AGED; ALLELE; ALZHEIMER DISEASE; ARTICLE; CONTROLLED STUDY; FEMALE; GENE FREQUENCY; GENOTYPE; HOMOZYGOSITY; HUMAN; MALE; PRIORITY JOURNAL; PROMOTER REGION; PROTEIN POLYMORPHISM; RISK FACTOR;

ADULT; AGED; AGED, 80 AND OVER; ALLELES; ALZHEIMER DISEASE; APOLIPOPROTEINS E; FEMALE; GENE FREQUENCY; GENETIC PREDISPOSITION TO DISEASE; GENOTYPE; HOMOZYGOTE; HUMANS; MALE; MIDDLE AGED; ODDS RATIO; POLYMORPHISM, GENETIC; PROMOTER REGIONS (GENETICS); REFERENCE VALUES;

EID: 0035947212     PISSN: 03043940     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0304-3940(01)01790-6     Document Type: Article

References (22)

1. Ahmed A.R.H., MacGowan S.H., Culpan D., Jones R.W., Wilcock G.K. The -491 A/T polymorphism of the Apolipoprotein E gene is associated with the ApoEε4 allele and Alzheimer's Disease. Neurosci. Lett. 263:1999;217-219.
2. Artiga M.J., Bullido M.J., Frank A., Sastre I., Recuero M., GarcÍa M.A., Lendon C.L., Han S.W., Morris J.C., Vázquez J., Goate A., Valdivieso F. Risk for Alzheimer's disease correlates with transcriptional activity of the APOE gene. Hum. Mol. Genet. 7:1998;1887-1892.
3. Artiga M.J., Bullido M.J., Sastre I., Recuero M., GarcÍa M.A., Aldudo J., Vazquez J., Valdivieso F. Allelic polymorphisms in the transcriptional regulatory region of apolipoprotein E gene. FEBS Letts. 421:1998;105-108.
4. Bales K.R., Verina T., Dodel R.C., Du Y., Altstiel L., Bender M., Hyslop P., Johnstone E.M., Little S.P., Cummins D.J., Piccardo P., Ghetti B., Paul S.M. Lack of apolipoprotein E dramatically reduces amyloid β-peptide deposition. Nat. Genet. 17:1997;263-264.
5. Bullido M.J., Artiga M.J., Recuero M., Sastre I., Garcia M.A., Aldudo J., Lendon C., Han S.W., Morris J.C., Frank A., Vazquez J., Goate A., Valdivieso F. A polymorphism in the regulatory region of APOE associated with risk for Alzheimer's dementia. Nat. Genet. 18:1998;69-71.
6. Casadei V.M., Ferri C., Veglia F., Gavazzi A., Salani G., Cattaneo M., Sorbi S., Annoni G., Licastro F., Mariani C., Franceschi M., Grimaldi L.M.E. APOE -491 promoter polymorphism is a risk factor for late-onset Alzheimer's disease. Neurology. 53:1999;1888-1889.
7. Chen L., Baum L., Ng H.K., Chan L.Y., Sastre I., Artiga M.J., Valdivieso F., Bullido M.J., Chiu H.F., Pang C.P. Apolipoprotein E promoter and α2-Macroglobulin polymorphisms are not genetically associated with Chinese late onset Alzheimer's disease. Neurosci. Lett. 269:1999;173-177.
8. Corder E.H., Saunders A.M., Strittmatter W.J., Schmechel D.E., Gaskell P.C., Small G.W., Roses A.D., Haines J.L., Pericak-Vance M.A. Gene dose of apolipoprotein E type 4 allele and the risk of Alzheimer's disease in late-onset families. Science. 261:1993;921-923.
9. Helisalmi S., Hiltunen M., Valonen P., Mannermaa A., Koivisto A.M., Lehtovirta M., Ryynänen M., Soininen H. Promoter polymorphism (-491 A/T) in the APOE gene of Finnish Alzheimer's disease patients and control individuals. J. Neurol. 246:1999;821-824.
10. Lambert J.C., Pérez-Tur J., Dupire M.J., Galasko D., Mann D., Amouyel P., Hardy J., Delacourte A., Chartier-Harlin M.C. Distortion of allelic expression of apolipoprotein E in Alzheimer's disease. Hum. Mol. Genet. 6:1997;2151-2154.
11. Lambert J.C., Berr C., Pasquier F., Delacourte A., Frigard B., Cottel D., Pérez-Tur J., Mouroux V., Mohr M., Cécyre D., Galasko D., Lendon C., Poirier J., Hardy J., Mann D., Amouyel P., Chartier-Harlin M.C. Pronounced impact of Th1/E47cs mutation compared with -491 AT mutation on neural APOE gene expression and risk of developing Alzheimer's disease. Hum. Mol. Genet. 7:1998;1511-1516.
12. Lambert J.C., Pasquier F., Cottel D., Frigard B., Amouyel P., Chartier-Harlin M.C. A new polymorphism in the APOE promoter associated with risk of developing Alzheimer's disease. Hum. Mol. Genet. 7:1998;533-540.
13. Laws S.M., Taddei K., Martins G., Paton A., Fisher C., Clarnette R., Hallmayer J., Brooks W.S., Gandy S.E., Martins R.N. The -491 AA polymorphism in the APOE gene is associated with increased plasma apoE levels in Alzheimer's disease. NeuroReport. 10:1999;879-882.
14. Mui S., Briggs M., Chung H., Wallace R.B., Gomez-Isla T., Rebeck G.W., Hyman B.T. A newly identified polymorphism in the apolipoprotein E enhancer gene region is associated with Alzheimer's disease and strongly with the ε4 allele. Neurology. 47:1996;196-201.
15. Roks G., Cruts M., Bullido M.J., Backhovens H., Artiga M.J., Hofman A., Valdivieso F., Van Broeckhoven C., Van Duijn C.M. The -491 A/T polymorphism in the regulatory region of the Apolipoprotein E gene and early-onset Alzheimer's disease. Neurosci. Lett. 258:1998;65-68.
16. Song Y.Q., Rogaeva E., Premkumar S., Brindle N., Kawarai T., Orlacchio A., Yu G., Levesque G., Nishimura M., Ikeda M., Pej Y., O'Toole C., Duara R., Barker W., Sorbi S., Freedman M., Farrer L., George-Hyslop P.S. Absence of association between Alzheimer disease and the -491 regulatory region polymorphism of APOE. Neurosci. Lett. 250:1998;189-192.
17. Taddei K., Clarnette R., Gandy S.E., Martins R.N. Increased plasma apolipoprotein E (apoE) levels in Alzheimer's disease. Neurosci. Lett. 223:1997;29-32.
18. Thome J., Gewirtz J.C., Sakai N., Zachariou V., Retz-Junginger P., Retz W., Duman R.S., Rösler M. Polymorphisms of the human apolipoprotein E promoter and bleomycin hydrolase gene: risk factors for Alzheimer's dementia? Neurosci. Lett. 274:1999;37-40.
19. Toji H., Maruyama H., Sasaki K., Nakamura S., Kawakami H., Apolipoprotein E. promoter polymorphism and sporadic Alzheimer's disease in a Japanese population. Neurosci. Lett. 259:1999;56-58.
20. Town T., Paris D., Fallin D., Duara R., Barker W., Gold M., Crawford F., Mullan M. The -491 A/T apolipoprotein E promoter polymorphism association with Alzheimer's disease: independent risk and linkage disequilibrium with the known APOE polymorphism. Neurosci. Lett. 252:1998;95-98.
21. Wang J.C., Kwon J.M., Shah P., Morris J.C., Goate A. Effect of APOE genotype and promoter polymorphism on risk of Alzheimer's disease. Neurology. 55:2000;1644-1649.
22. Zurutuza L., Verpillat P., Raux G., Hannequin D., Puel M., Belliard S., Michon A., Pothin Y., Camuzat A., Penet C., Martin C., Brice A., Campion D., Clerget-Darpoux F., Frebourg T. APOE promoter polymorphisms do not confer independent risk for Alzheimer's disease in a French population. Eur. J. Hum. Genet. 8:2000;713-716.